Skip to Main content Skip to Navigation
Journal articles

Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT)

Serge Bernard 1 R. Loffroy 2 A. Serusclat 2 L. Boussel 2 E. Bonnefoy 3 C. Thevenon M. Rabilloud 4 D. Revel 2 P. Moulin 1 P. Douek 2 
3 Evaluation et modélisation des effets thérapeutiques
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
4 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Abstract : Objective: The combination of both morphological and cellular markers of subclinical atherosclerosis, in addition to conventional risk factors, may help to improve cardiovascular prevention in type 2 diabetic patients. The aim of our cross-sectional study was to evidence a putative increase in endothelial (EMP) or platelet (PMP) microparticles, in type 2 diabetic patients with coronary noncalcified plaques detected by multidetector CT (MDCT). Methods and results: Microparticles and coronary MDCT were assessed in 56 type 2 diabetic patients with different cardiovascular risk levels. Both EMP (r=0.35, p=0.022) and PMP (rho=0.34, p=0.022) were correlated with hsCRP. EMP were elevated in patients with acute coronary syndromes (p=0.034). EMP count was significantly higher in the presence of noncalcified diseased segments (p=0.01). By contrast, there was no association between hsCRP and noncalcified atheroma. This increase in EMP in noncalcified diseased segment carriers remained borderline significant after adjustment for coronary heart disease and hsCRP. Conversely, there was no association of PMP count with noncalcified diseased segments and no difference in PMP count between patients with and without acute coronary syndrome. No significant association between either EMP and PMP counts and mixed or calcified diseased segments was observed. Conclusions: We report for the first time an association between plasma EMP-CD144+ and coronary noncalcified plaques assessed by MDCT in a population of type 2 diabetic patients. EMP might be used as a surrogate marker of unstable plaques, and might help to improve cardiovascular prediction in diabetic patients with intermediate risk.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00443146
Contributor : Compte Général Laboratoire Creatis Connect in order to contact the contributor
Submitted on : Tuesday, December 29, 2009 - 4:12:25 PM
Last modification on : Thursday, August 4, 2022 - 5:13:54 PM

Identifiers

Citation

Serge Bernard, R. Loffroy, A. Serusclat, L. Boussel, E. Bonnefoy, et al.. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis, Elsevier, 2009, 203 (2), pp.429-435. ⟨10.1016/j.atherosclerosis.2008.07.039⟩. ⟨hal-00443146⟩

Share

Metrics

Record views

173